APO Research
Talk to an analyst

APO RESEARCH · REPORT

Entereg (alvimopan)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Entereg (alvimopan) Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchEntereg (alvimopan) Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal Entereg (alvimopan) Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Entereg (alvimopan) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Entereg (alvimopan) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Entereg (alvimopan) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Entereg (alvimopan) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Entereg (alvimopan) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Entereg (alvimopan) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Entereg (alvimopan) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Entereg (alvimopan) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Entereg (alvimopan) market include Merck. among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Entereg (alvimopan) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Entereg (alvimopan) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Entereg (alvimopan) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Entereg (alvimopan) market.

Entereg (alvimopan) Segment by Company

Merck

Entereg (alvimopan) Segment by Type

12 mg Capsule

Type II

Entereg (alvimopan) Segment by Application

Partial bowel resection

Radical cystectomy

Entereg (alvimopan) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Entereg (alvimopan) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Entereg (alvimopan) key companies, revenue, market share, and recent developments.

3. To split the Entereg (alvimopan) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Entereg (alvimopan) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Entereg (alvimopan) significant trends, drivers, influence factors in global and regions.

6. To analyze Entereg (alvimopan) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Entereg (alvimopan) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Entereg (alvimopan) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Entereg (alvimopan).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Entereg (alvimopan) industry.

Chapter 3: Detailed analysis of Entereg (alvimopan) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Entereg (alvimopan) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Entereg (alvimopan) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Entereg (alvimopan) Industry Trends Table 2. Entereg (alvimopan) Industry Drivers Table 3. Entereg (alvimopan) Industry Opportunities and Challenges Table 4. Entereg (alvimopan) Industry Restraints Table 5. Global Entereg (alvimopan) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Entereg (alvimopan) Revenue Share by Company (2021-2026) Table 7. Global Entereg (alvimopan) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Entereg (alvimopan) Key Company Manufacturing Base & Headquarters Table 9. Global Entereg (alvimopan) Company, Product Type & Application Table 10. Global Entereg (alvimopan) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Entereg (alvimopan) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 12 mg Capsule Table 15. Significant Companies of Type II Table 16. Global Entereg (alvimopan) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Entereg (alvimopan) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Entereg (alvimopan) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Entereg (alvimopan) Sales Value Share by Type (2021-2026) Table 20. Global Entereg (alvimopan) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Partial bowel resection Table 22. Significant Companies of Radical cystectomy Table 23. Global Entereg (alvimopan) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Entereg (alvimopan) Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Entereg (alvimopan) Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Entereg (alvimopan) Sales Value Share by Application (2021-2026) Table 27. Global Entereg (alvimopan) Sales Value Share by Application (2027-2032) Table 28. Global Entereg (alvimopan) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Entereg (alvimopan) Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Entereg (alvimopan) Sales Value Share by Region (2021-2026) Table 31. Global Entereg (alvimopan) Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Entereg (alvimopan) Sales Value Share by Region (2027-2032) Table 33. Global Entereg (alvimopan) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Entereg (alvimopan) Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Entereg (alvimopan) Sales Value Market Share by Country (2021-2026) Table 36. Global Entereg (alvimopan) Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Entereg (alvimopan) Sales Value Market Share by Country (2027-2032) Table 38. Merck Company Information Table 39. Merck Business Overview Table 40. Merck Entereg (alvimopan) Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Merck Entereg (alvimopan) Product Portfolio Table 42. Merck Recent Development Table 43. Research Programs/Design for This Report Table 44. Authors List of This Report Table 45. Secondary Sources Table 46. Primary Sources List of Figures Figure 1. Entereg (alvimopan) Product Image Figure 2. Global Entereg (alvimopan) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Entereg (alvimopan) Market Size (2021-2032) & (US$ Million) Figure 4. Global Entereg (alvimopan) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 12 mg Capsule Image Figure 8. Type II Image Figure 9. Global Entereg (alvimopan) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Entereg (alvimopan) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Entereg (alvimopan) Sales Value Share by Type (2021-2032) Figure 12. Partial bowel resection Image Figure 13. Radical cystectomy Image Figure 14. Global Entereg (alvimopan) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Entereg (alvimopan) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Entereg (alvimopan) Sales Value Share by Application (2021-2032) Figure 17. Global Entereg (alvimopan) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Entereg (alvimopan) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Entereg (alvimopan) Sales Value (2021-2032) & (US$ Million) Figure 20. North America Entereg (alvimopan) Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Entereg (alvimopan) Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Entereg (alvimopan) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Entereg (alvimopan) Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Entereg (alvimopan) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Entereg (alvimopan) Sales Value (2021-2032) & (US$ Million) Figure 26. South America Entereg (alvimopan) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Entereg (alvimopan) Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Entereg (alvimopan) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Entereg (alvimopan) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • 12 mg Capsule
  • Type II
Applications
  • Partial bowel resection
  • Radical cystectomy
Companies covered
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Entereg (alvimopan) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Entereg (alvimopan) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Entereg (alvimopan) Market Dynamics
  1. 2.1 Entereg (alvimopan) Industry Trends
  2. 2.2 Entereg (alvimopan) Industry Drivers
  3. 2.3 Entereg (alvimopan) Industry Opportunities and Challenges
  4. 2.4 Entereg (alvimopan) Industry Restraints
3 Entereg (alvimopan) Market by Company
  1. 3.1 Global Entereg (alvimopan) Company Revenue Ranking in 2025
  2. 3.2 Global Entereg (alvimopan) Revenue by Company (2021-2026)
  3. 3.3 Global Entereg (alvimopan) Company Ranking (2024-2026)
  4. 3.4 Global Entereg (alvimopan) Company Manufacturing Base and Headquarters
  5. 3.5 Global Entereg (alvimopan) Company Product Type and Application
  6. 3.6 Global Entereg (alvimopan) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Entereg (alvimopan) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Entereg (alvimopan) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Entereg (alvimopan) Market by Type
  1. 4.1 Entereg (alvimopan) Type Introduction
  2. 4.1.1 12 mg Capsule
  3. 4.1.2
  4. 4.2 Global Entereg (alvimopan) Sales Value by Type
  5. 4.2.1 Global Entereg (alvimopan) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Entereg (alvimopan) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Entereg (alvimopan) Sales Value Share by Type (2021-2032)
5 Entereg (alvimopan) Market by Application
  1. 5.1 Entereg (alvimopan) Application Introduction
  2. 5.1.1 Partial bowel resection
  3. 5.1.2 Radical cystectomy
  4. 5.2 Global Entereg (alvimopan) Sales Value by Application
  5. 5.2.1 Global Entereg (alvimopan) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Entereg (alvimopan) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Entereg (alvimopan) Sales Value Share by Application (2021-2032)
6 Entereg (alvimopan) Regional Value Analysis
  1. 6.1 Global Entereg (alvimopan) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Entereg (alvimopan) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Entereg (alvimopan) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Entereg (alvimopan) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Entereg (alvimopan) Sales Value (2021-2032)
  7. 6.3.2 North America Entereg (alvimopan) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Entereg (alvimopan) Sales Value (2021-2032)
  10. 6.4.2 Europe Entereg (alvimopan) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Entereg (alvimopan) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Entereg (alvimopan) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Entereg (alvimopan) Sales Value (2021-2032)
  16. 6.6.2 South America Entereg (alvimopan) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Entereg (alvimopan) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Entereg (alvimopan) Sales Value Share by Country, 2025 VS 2032
7 Entereg (alvimopan) Country-level Value Analysis
  1. 7.1 Global Entereg (alvimopan) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Entereg (alvimopan) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Entereg (alvimopan) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Entereg (alvimopan) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Entereg (alvimopan) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Entereg (alvimopan) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Entereg (alvimopan) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Entereg (alvimopan) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Entereg (alvimopan) Product Portfolio
  6. 8.1.5 Merck Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst